Skip to content
value.today

Trilogy MedWaste, Inc.

🇺🇸 Houston, Texas, USAHealth CareFounded 2017
Total raised
$10 M
1 round on record
Latest round
$10 M
Dec 2017
First round on record
Dec 2017
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Trilogy MedWaste, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2017$10 MNo. 1$10 to $50 million

Trilogy MedWaste, Inc.: Raise no. 1, Dec 2017

Investors in this round

6 investors had bought by the notice of Dec 29, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bobby R Clark, Jr. · Executive Officer · Vice President, Operations
  • David R Farrar · Executive Officer · Director of Operations
  • Gregory M Fields · Executive Officer · Vice President, Business Development
  • Michael B Mamaux · Executive Officer · Vice President and Secretary
  • Michael M Fields · Executive Officer, Director · President and Chief Executive Officer
  • Raymond P Hart · Executive Officer · Vice President, Mergers and Acquisitions
  • Ali R Satvat · Director
  • Justin R Sabet-Peyman · Director
  • Tommy R Dorsey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Mamaux, Vice President. Source: SEC Form D, newest notice filed Dec 29, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Trilogy MedWaste, Inc. had no revenue when it filed its newest notice of a funding round (Dec 2017).

    SEC Form D (revenue range) · Dec 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2017

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Trilogy MedWaste, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Trilogy MedWaste, Inc.
NameRoleNamed in
Bobby R Clark, Jr.Vice President, OperationsDec 2017
David R FarrarDirector of OperationsDec 2017
Gregory M FieldsVice President, Business DevelopmentDec 2017
Michael B MamauxVice President and SecretaryDec 2017
Michael M FieldsPresident and Chief Executive OfficerDec 2017
Raymond P HartVice President, Mergers and AcquisitionsDec 2017
Ali R SatvatDirectorDec 2017
Justin R Sabet-PeymanDirectorDec 2017
Michael M FieldsPresident and Chief Executive OfficerDec 2017
Tommy R DorseyDirectorDec 2017